ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173905 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173905; 2) Community: the network communities that were significantly associated with the response to NSC 173905; 3) Molecule: the relationships between components within communities and NSC 173905; 4) MDR: the compounds that were significantly associated with the NSC 173905.

NSC Compound Enrichment Correlation
NSC 3088 Chlorambucil 0.0421163101172308 0.34666177
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0421163101172308 0.38910911
NSC 46213 Null 0.0421163101172308 -0.20151184
NSC 600758 Null 0.0421163101172308 0.63998809
NSC 625500 Null 0.0421163101172308 0.51639781
NSC 625505 Null 0.0421163101172308 0.28273401
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0421163101172308 0.36739392
NSC 631391 7H-Pyrido[4,3-c]carbazole-6-methanol,methylcarbamate (ester) (9CI) 0.0421163101172308 0.43424228
NSC 634036 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0421163101172308 0.43967815
NSC 639174 Camptothecin Derivative 0.0421163101172308 0.20382274
Total:116  Current:105    [First] [Prev] [Next] [Last]